Boston Scientific (BSX) Q1 2026 Preview: $0.79 EPS Expected, Up Year-Over-Year
BSX|EPS Est $0.79 (25 analysts)|Rev Est $5.17B|Reports on 2026-04-22 Wall Street expects modest growth when Boston Scientific Corporation reports its first-quarter 2026 results on April 22. The consensus among 25 analysts calls for earnings of $0.79 per share on revenue of $5.17B. Estimates show a tight clustering, with EPS projections ranging from $0.77 to $0.83 […]
Boston Scientific (BSX) Q1 2026 Preview: $0.79 EPS Expected, Up Year-Over-Year Read More »


